Actively Recruiting
Exploration of Health Literacy in Diabetes in Reunion Island and Metropolitan France
Led by Centre Hospitalier Universitaire de la Réunion · Updated on 2025-07-30
1350
Participants Needed
2
Research Sites
8 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This observational study aims to explore the health literacy profiles of patients with type 1, type 2, or gestational diabetes in Reunion Island and metropolitan France. The goal is to gather information that can help improve access to health information, therapeutic education, and health services for diabetic patients. The study is sponsored by the Centre Hospitalier Universitaire de la Réunion. Participants in this study will complete the Health Literacy Questionnaire (HLQ) one time. This questionnaire is designed to assess various aspects of health literacy related to managing diabetes. The study does not involve any treatment or intervention beyond this questionnaire. During the study, participants will complete the HLQ once at the time of inclusion. Researchers will analyze the health literacy profiles based on the questionnaire results. The primary outcome measure is the health literacy profile in Reunion Island at inclusion, with secondary measures including profiles from both Reunion Island and France. Participants will not undergo any additional procedures, and the total participation time is limited to the completion of the questionnaire.
CONDITIONS
Brief Title
Exploration of Health Literacy in Diabetes in Reunion Island and France
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Patient with type 1, 2 or gestational diabetes taken care in hospital
- Age 18 years or older
You will not qualify if you...
- Patient unable to understand and respect study procedures
- Patient with cognitive disorder
- Patient with serious acute complication due to diabetes within 15 days before inclusion
- Stroke history with neurologic consequences
- Other specific types of diabetes: chronic calcific pancreatitis, iatrogenic, other secondary diabetes, rare monogenic or genetic diabetes due to insulin resistance
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
Duration - At inclusion
Participants complete a health literacy questionnaire related to their diabetes condition.
1 visit (in-person)
Trial Site Locations
Total: 2 locations
1
CHU de La Réunion
Saint-Denis, Reunion, 97400
Not Yet Recruiting
2
CHU de La Réunion
Saint-Denis, Reunion
Actively Recruiting
Research Team
A
Anna FLAUS
X
Xavier DEBUSSCHE
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here